Literature DB >> 28444583

Editorial Comment: 2016 Musculoskeletal Infection Society Proceedings.

Charalampos G Zalavras1, Bryan D Springer2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28444583      PMCID： PMC5449341          DOI： 10.1007/s11999-017-5357-y

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN： 0009-921X            Impact factor:   4.176


× No keyword cloud information.
  3 in total

1.  Vancomycin Prophylaxis for Total Joint Arthroplasty: Incorrectly Dosed and Has a Higher Rate of Periprosthetic Infection Than Cefazolin.

Authors:  Michael M Kheir; Timothy L Tan; Ibrahim Azboy; Dean D Tan; Javad Parvizi
Journal:  Clin Orthop Relat Res       Date:  2017-07       Impact factor: 4.176

2.  Periprosthetic joint infection increases the risk of one-year mortality.

Authors:  Benjamin Zmistowski; Joseph A Karam; Joel B Durinka; David S Casper; Javad Parvizi
Journal:  J Bone Joint Surg Am       Date:  2013-12-18       Impact factor: 5.284

3.  Two-stage treatment of hip periprosthetic joint infection is associated with a high rate of infection control but high mortality.

Authors:  Keith R Berend; Adolph V Lombardi; Michael J Morris; Adam G Bergeson; Joanne B Adams; Michael A Sneller
Journal:  Clin Orthop Relat Res       Date:  2013-02       Impact factor: 4.176
  3 in total
  1 in total

1.  Projections and Epidemiology of Revision Hip and Knee Arthroplasty in the United States to 2030.

Authors:  Andrew M Schwartz; Kevin X Farley; George N Guild; Thomas L Bradbury
Journal:  J Arthroplasty       Date:  2020-02-19       Impact factor: 4.757
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.